/content/dam/www/people-profile-photos/l/michael-linenberger/michael-linenberger-d.jpg
Linenberger
Michael Linenberger, MD

Michael Linenberger, MD

  • Professor Emeritus, Clinical Research Division, Fred Hutch
  • Professor Emeritus, Hematology/Oncology, University of Washington

Background

Dr. Michael Linenberger is a hematologist who treats patients with blood cancers such as leukemia, lymphoma, myeloproliferative neoplasms and myelodysplastic syndromes, or blood disorders such as anemia, sickle cell disease, thrombosis and bleeding. His research focuses on apheresis, the procedure for removing specific cell types from blood. He is an expert in bone marrow and peripheral blood stem cell procurement for transplantation, collection of immune effector cells, and safety issues for patients and recipients of cell-based therapies.

Education

MD, University of Kansas, Kansas City, 1982

BS, University of Kansas, 1978

Find a Clinical Trial

View All Trials

Stories

All news
Leader in apheresis and cellular therapy, Dr. Michael Linenberger, retires
Leader in apheresis and cellular therapy, Dr. Michael Linenberger, retires As professor emeritus, this respected mentor will continue to contribute to the UW fellowship program December 16, 2022
Dr. Michael Linenberger honored for contributions to apheresis medicine
Dr. Michael Linenberger honored for contributions to apheresis medicine Presidential Award from American Society for Apheresis recognizes hematologist’s two decades of service March 7, 2022
Attending with compassionate care
Attending with compassionate care Ali Johany award recipient Dr. Michael Linenberger sets "excellence as a standard" in care for blood stem-cell transplant patients, families March 17, 2005